Zobrazeno 1 - 10
of 389
pro vyhledávání: '"McCaleb ML"'
Autor:
Ganz T; Department of Medicine and Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. Tganz@mednet.ucla.edu., Nemeth E; Department of Medicine, University of California, Los Angeles, CA, 90095, USA., Rivella S; Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia (CHOP), 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA.; Cell and Molecular Biology Graduate Group (CAMB), University of Pennsylvania, Abramson Research Center, 3615 Civic Center Boulevard, Room 316B, Philadelphia, PA, 19104, USA., Goldberg P; Prilenia Therapeutics, Herzliya, Israel.; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Dibble AR; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., McCaleb ML; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Guo S; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Monia BP; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Barrett TD; Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA. TBarrett@ionisph.com.
Publikováno v:
Advances in therapy [Adv Ther] 2023 Apr; Vol. 40 (4), pp. 1317-1333. Date of Electronic Publication: 2023 Jan 23.
Autor:
Weng SY; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Wang X; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Vijayan S; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Tang Y; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University, Mainz, Germany., Kim YO; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Padberg K; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Regen T; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University, Mainz, Germany., Molokanova O; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Chen T; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Bopp T; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Institute for Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany., Schild H; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Institute for Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany., Brombacher F; International Center for Genetic Engineering and Biotechnology, Institute of Infectious Disease and Molecular Medicine, South African Medical Research Council, Cape Town, South Africa., Crosby JR; Ionis Pharmaceuticals, Carlsbad, CA, United States., McCaleb ML; Ionis Pharmaceuticals, Carlsbad, CA, United States., Waisman A; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Institute for Molecular Medicine, University Medical Center, Johannes Gutenberg University, Mainz, Germany., Bockamp E; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Schuppan D; Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University, Mainz, Germany; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: detlef.schuppan@unimedizin-mainz.de.
Publikováno v:
EBioMedicine [EBioMedicine] 2018 Mar; Vol. 29, pp. 92-103. Date of Electronic Publication: 2018 Feb 17.
Autor:
Grossman TR; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Carrer M; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Shen L; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Johnson RB; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Hettrick LA; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Henry SP; Ionis Pharmaceuticals, Inc., Carlsbad, CA., Monia BP; Ionis Pharmaceuticals, Inc., Carlsbad, CA., McCaleb ML; Ionis Pharmaceuticals, Inc., Carlsbad, CA.
Publikováno v:
Molecular vision [Mol Vis] 2017 Aug 10; Vol. 23, pp. 561-571. Date of Electronic Publication: 2017 Aug 10 (Print Publication: 2017).
Autor:
Grossman TR; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA. Electronic address: tgrossman@isisph.com., Hettrick LA; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Johnson RB; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Hung G; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Peralta R; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Watt A; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Henry SP; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., Adamson P; GSK Ophthalmology, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom., Monia BP; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA., McCaleb ML; Department of Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, USA.
Publikováno v:
Immunobiology [Immunobiology] 2016 Jun; Vol. 221 (6), pp. 701-8. Date of Electronic Publication: 2015 Aug 10.
Autor:
Billioud G; The Scripps Research Institute, La Jolla, CA, USA., Kruse RL; Baylor College of Medicine, Houston, TX, USA., Carrillo M; The Scripps Research Institute, La Jolla, CA, USA., Whitten-Bauer C; The Scripps Research Institute, La Jolla, CA, USA., Gao D; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA., Kim A; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA., Chen L; Baylor College of Medicine, Houston, TX, USA., McCaleb ML; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA., Crosby JR; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA., Hamatake R; GlaxoSmithKline, Research Triangle Park, NC, USA., Hong Z; GlaxoSmithKline, Research Triangle Park, NC, USA., Garaigorta U; The Scripps Research Institute, La Jolla, CA, USA., Swayze E; Ionis Pharmaceuticals Inc., Carlsbad, CA, USA. Electronic address: eswayze@ionisph.com., Bissig KD; Baylor College of Medicine, Houston, TX, USA. Electronic address: bissig@bcm.edu., Wieland S; The Scripps Research Institute, La Jolla, CA, USA. Electronic address: swieland@scripps.edu.
Publikováno v:
Journal of hepatology [J Hepatol] 2016 Apr; Vol. 64 (4), pp. 781-9. Date of Electronic Publication: 2015 Nov 30.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Murray SF; Isis Pharmaceuticals Carlsbad, California, United States., Jazayeri A; Isis Pharmaceuticals Carlsbad, California, United States., Matthes MT; University of California at San Francisco School of Medicine, Beckman Vision Center, San Francisco, California, United States., Yasumura D; University of California at San Francisco School of Medicine, Beckman Vision Center, San Francisco, California, United States., Yang H; University of California at San Francisco School of Medicine, Beckman Vision Center, San Francisco, California, United States., Peralta R; Isis Pharmaceuticals Carlsbad, California, United States., Watt A; Isis Pharmaceuticals Carlsbad, California, United States., Freier S; Isis Pharmaceuticals Carlsbad, California, United States., Hung G; Isis Pharmaceuticals Carlsbad, California, United States., Adamson PS; GlaxoSmithKlein, Brentford, Middlesex, United Kingdom., Guo S; Isis Pharmaceuticals Carlsbad, California, United States., Monia BP; Isis Pharmaceuticals Carlsbad, California, United States., LaVail MM; University of California at San Francisco School of Medicine, Beckman Vision Center, San Francisco, California, United States., McCaleb ML; Isis Pharmaceuticals Carlsbad, California, United States.
Publikováno v:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2015 Oct; Vol. 56 (11), pp. 6362-75.
Autor:
Wanner A; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Groft SC; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Teagarden JR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Krischer J; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Davis BR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Coffey CS; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Hickam DH; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Teckman J; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Nelson DR; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., McCaleb ML; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Loomba R; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Strange C; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Sandhaus RA; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Brantly M; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Edelman JM; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida., Farrugia A; Division of Pulmonary and Critical Care Medicine, University of Miami and Alpha-1 Foundation, Miami, Florida.
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2015 Apr 28; Vol. 2 (2), pp. 177-190. Date of Electronic Publication: 2015 Apr 28.
Autor:
Abd El-Aal, Hassan A. K.1 hassankotb33@yahoo.com
Publikováno v:
Australian Journal of Chemistry. 2023, Vol. 76 Issue 11, p760-773. 14p.
Autor:
Guo S; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Booten SL; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Watt A; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Alvarado L; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Freier SM; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Teckman JH; Department of Pediatrics; St. Louis University School of Medicine; St. Louis, MO USA., McCaleb ML; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA., Monia BP; Antisense Drug Discovery; Isis Pharmaceuticals; Carlsbad, CA USA.
Publikováno v:
Rare diseases (Austin, Tex.) [Rare Dis] 2014 Mar 12; Vol. 2, pp. e28511. Date of Electronic Publication: 2014 Mar 12 (Print Publication: 2014).